Nanobodies conjugated with isotopes have been applied for tumor imaging as a non-invasive diagnostic modality through targeting various tumor biomarkers such as HER2, Claudin18.2, fibronectin, etc. [28, 45, 47]. This evidence concerns the gene ERBB2 and neoplasm.